Although this won't happen from just a few cups of tea daily, there have been recent cases where habitually drinking extremely large amounts of tea has caused "fluorosis" causing bone pain and even tooth loss
Ozempic is not labeled as a chronic weight-management product, and injection-study outcomes should not be copied to tablets or compared directly with separate Wegovy trials as if the studies were interchangeable
Focus on your health goals while we manage the paperwork, ensuring you can access the treatment you need with ease
Additional well-designed, prospective studies are needed to confirm the potential benefit of GLP-1 receptor agonist treatment for patients with advanced CKD or ESKD." For further information: DOI: 10.1001/jamanetworkopen.2022.1169 Keywords: CKD, ESKD, GLP-1 receptor agonist, DPP-4 inhibitors, type 2 diabetes, JAMA Network Open, chronic kidney disease, end-stage kidney disease, National Health Insurance Research Database of Taiwan, MACCE, Mortality rate